CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Lung UltrasoundWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.13
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials


1 Predicting Outcomes for Covid-19 Using Sonography

This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.

NCT04384055 COVID-19 Pneumonia, Viral Diagnostic Test: Lung Ultrasound
MeSH:Pneumonia, Viral Pneumonia
HPO:Pneumonia

Primary Outcomes

Description: Composite primary outcome of death, ICU admission, mechanical ventilation, or use of high-flow nasal cannula (categorical)

Measure: Number of Patients Experiencing Death, ICU Admission, Mechanical Ventilation, or Use of High-Flow Nasal Cannula

Time: 28 days from initial evaluation

Secondary Outcomes

Measure: Number of Patients Requiring Mechanical Ventilation

Time: 28 days from initial evaluation

Measure: Number of Patients Requiring Supplemental Oxygen Usage

Time: 28 days from initial evaluation

Measure: Duration of Supplemental Oxygen Usage

Time: 28 days from initial evaluation

Description: Duration of Hospitalization (days)

Measure: Length of Stay

Time: 28 days from initial evaluation

Description: Descriptive analysis of ultrasound findings in Covid-19

Measure: Characterization of Ultrasound Findings

Time: 28 days from initial evaluation


Related HPO nodes (Using clinical trials)